Health care startups that raised Series B in California, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Prolific Machines | Emeryville | Series B | $50.0M | 2026-10-14 |
| Multiply Labs | San Francisco | Series B | $75.0M | 2026-10-06 |
| Moonwalk Biosciences | South San Francisco | Series B | $70.0M | 2026-09-08 |
| N-Power Medicine | Redwood City | Series B | $32.0M | 2026-09-01 |
| Faro AI | San Diego | Series B | $37.3M | 2026-08-26 |
| Aureka Biotechnologies | Laguna Hills | Series B | $100.0M | 2026-08-10 |
| Bunkerhill Health | Palo Alto | Series B | $25.0M | 2026-07-16 |
| Materna Medical | Mountain View | Series B | $5.0M | 2026-07-01 |
8 rows of the CSV in 5 of its 18 columns.
- The 441 health care startups in California, United States whose last round is Series B have raised $26.5B in total.
- 51 of them closed their most recent round in the last 12 months, $3.0B combined.
- The largest of those rounds is Mirador Therapeutics' $250.0M Series B, dated January 2026.
- The most recent is Prolific Machines' $50.0M Series B on 14 October 2026.
- Y Combinator is an investor in 6 of them, more than any other fund.
- Biotech is the most common other sector, with 203 companies (46%).
- 15% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 11 to 50 employees (48% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
30 of 441| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Prolific Machines | Prolific Machines develops light-controlled gene expression systems for producing therapeutics. | Artificial intelligence | Emeryville | Series B | $50.0M | 2026-10-14 | $147.0M | SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 | 51 to 100 | 2020 |
| Multiply Labs | Multiply Labs builds robotic systems that automate biologics manufacturing. | Artificial intelligence | San Francisco | Series B | $75.0M | 2026-10-06 | $97.7M | Y Combinator, Founders Fund, Garage Capital +2 | 11 to 50 | 2016 |
| Moonwalk Biosciences | Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. | Artificial intelligence | South San Francisco | Series B | $70.0M | 2026-09-08 | $127.0M | Google Ventures, Khosla Ventures, ARCH Venture Partners +2 | 11 to 50 | 2022 |
| N-Power Medicine | N-Power Medicine is a biotechnology company that uses AI to offer clinical research and drug development services. | Artificial intelligence | Redwood City | Series B | $32.0M | 2026-09-01 | $104.0M | Merck Global Health Innovation Fund | 101 to 250 | 2021 |
| Faro AI | Faro AI develops software that automates clinical workflows and assists with clinical trial design. | Artificial intelligence | San Diego | Series B | $37.3M | 2026-08-26 | $72.3M | General Catalyst, Polaris Partners, Zetta Venture Partners +2 | 11 to 50 | 2019 |
| Aureka Biotechnologies | Aureka Biotechnologies uses AI to discover protein therapeutics and antibody treatments. | Artificial intelligence | Laguna Hills | Series B | $100.0M | 2026-08-10 | $168.4M | K2VC, NRL Capital | 11 to 50 | 2023 |
| Bunkerhill Health | Bunkerhill Health develops AI agents that enhance clinical and operational teams within health systems. | Artificial intelligence | Palo Alto | Series B | $25.0M | 2026-07-16 | $55.0M | Y Combinator, SciFi VC, Pacific 8 Ventures | 11 to 50 | 2022 |
| Materna Medical | Materna Medical develops medical devices that help women protect and restore their pelvic health. | Health care | Mountain View | Series B | $5.0M | 2026-07-01 | $62.6M | Golden Seeds, Band of Angels, Wavemaker 360 +2 | 11 to 50 | 2010 |
| xCures | xCures aggregates, organizes, and structures electronic medical records across multiple diseases and data types. | Artificial intelligence | Oakland | Series B | $46.0M | 2026-06-24 | $59.0M | Metaplanet, Wavemaker 360, Portfolia +2 | 11 to 50 | 2018 |
| California Naturals | California Naturals sells clean, safe, natural personal care goods at affordable prices. | Health care | Los Angeles | Series B | $21.0M | 2026-06-03 | $25.0M | L Catterton, Elizabeth Street Ventures, Midnight Venture Partners +2 | 1 to 10 | 2023 |
| Triomics | Triomics matches patients to clinical trials using generative AI technology. | Artificial intelligence | San Francisco | Series B | $22.0M | 2026-05-27 | $37.1M | Y Combinator, Lightspeed Venture Partners, General Catalyst +2 | 51 to 100 | 2021 |
| 9amHealth | 9amHealth offers a simplified approach to whole body health, including weight loss and diabetes management. | Health care | Encinitas | Series B | $26.0M | 2026-05-12 | $55.2M | Founders Fund, Speedinvest, StartUp Health +2 | 251 to 500 | 2021 |
| LTZ Therapeutics | LTZ Therapeutics develops novel immunotherapies for cancer and other diseases with unmet clinical needs. | Biotech | San Francisco | Series B | $38.0M | 2026-05-06 | $125.0M | Qiming Venture Partners, Shunwei Capital, K2VC +1 | 11 to 50 | 2022 |
| Qualified Health | Qualified Health develops AI tools that support clinical decisions and patient care management. | Artificial intelligence | San Carlos | Series B | $125.0M | 2026-03-25 | $155.0M | SignalFire, Flare Capital Partners, Town Hall Ventures +1 | 51 to 100 | 2023 |
| Unnatural Products | Unnatural Products is a biotech company that develops macrocyclic peptide drug therapies. | Artificial intelligence | Santa Cruz | Series B | $45.0M | 2026-03-16 | $83.0M | Abstract, Better Ventures, Artis Ventures +2 | 11 to 50 | 2017 |
| BreezeBio | BreezeBio is a biotechnology company that develops genetic therapies using non-viral delivery to clinically important tissues. | Artificial intelligence | Brisbane | Series B | $60.0M | 2026-02-25 | $127.7M | Sequoia Capital, National Science Foundation, Qiming Venture Partners +1 | 51 to 100 | 2016 |
| Mirador Therapeutics | Mirador Therapeutics develops precision medicines for immune-mediated diseases. | Biotech | San Diego | Series B | $250.0M | 2026-01-12 | $730.0M | OrbiMed, Fidelity, ARCH Venture Partners +1 | 11 to 50 | 2024 |
| Apella Technology | Apella Technology is an AI company that applies modern engineering to improve surgical procedures. | Artificial intelligence | Oakland | Series B | $80.0M | 2026-01-07 | $104.0M | Operator Partners, Upside Partnership, Casdin Capital +1 | 51 to 100 | 2019 |
| Aeovian Pharmaceuticals | Aeovian Pharmaceuticals develops and commercializes therapeutics for rare and age-related diseases. | Biotech | San Francisco | Series B | $55.0M | 2025-12-16 | $142.0M | Sofinnova Investments, venBio Partners, Apollo Health Ventures | 1 to 10 | 2012 |
| BlossomHill Therapeutics | BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. | Biotech | San Diego | Series B | $84.0M | 2025-12-10 | $257.0M | OrbiMed, Cormorant Asset Management, Vivo Capital +2 | 11 to 50 | 2020 |
| Sovato Health | Sovato Health provides surgical access through remote robotic surgeon options. | Health care | Santa Barbara | Series B | $41.0M | 2025-11-04 | $41.0M | Polaris Partners | 11 to 50 | 2022 |
| Avenzo Therapeutics | Avenzo Therapeutics develops oncology therapies for treating cancer. | Biotech | San Diego | Series B | $60.0M | 2025-09-04 | $841.9M | New Enterprise Associates, Sands Capital Ventures, Lilly Asia Ventures +2 | 11 to 50 | 2022 |
| Arbital Health | Arbital Health provides neutral adjudication for outcomes-based healthcare contracts. | Health care | Santa Rosa | Series B | $31.0M | 2025-07-29 | $41.0M | Flex Capital, Transformation Capital, Underdog Labs +2 | 1 to 10 | 2023 |
| Actio Biosciences | Actio Biosciences develops drugs for rare diseases through its research center. | Biotech | San Diego | Series B | $66.0M | 2025-06-18 | $121.0M | Canaan Partners, Euclidean Capital, Deerfield Management +2 | 11 to 50 | 2021 |
| Lykos Therapeutics | Lykos Therapeutics develops psychedelic drugs and trains therapists to support patient healing. | Education | San Jose | Series B | $50.0M | 2025-05-30 | $150.0M | True Ventures, KittyHawk, Satori Capital +1 | 101 to 250 | 2014 |
| Sirius Therapeutics | Sirius Therapeutics is a biotechnology company developing RNAi therapies for cardiovascular diseases. | Biotech | San Diego | Series B | $50.0M | 2025-05-09 | $110.0M | OrbiMed, Hankang Capital, Creacion Ventures +1 | 11 to 50 | 2021 |
| Carta Healthcare | Carta Healthcare helps hospitals tailor patient care to each individual's needs. | Artificial intelligence | San Francisco | Series B | $18.2M | 2025-05-07 | $60.5M | Alchemist Accelerator, MaC Venture Capital, Maverick Ventures +1 | 51 to 100 | 2017 |
| Airvet | Airvet offers a pet care benefit that helps employers save time and money on pet care costs. | Health care | Walnut Creek | Series B | $11.0M | 2025-04-01 | $43.2M | Headline, Verissimo Ventures, Canvas Prime +2 | 51 to 100 | 2018 |
| Gallant | Gallant advances investigational stem cell therapies to extend the healthy years of pets. | Biotech | San Diego | Series B | $18.0M | 2025-03-15 | $44.0M | Alumni Ventures, Bling Capital, Science +2 | 11 to 50 | 2018 |
| Zeto | Zeto makes a wireless, dry electrode EEG headset for hospitals, backed by a cloud platform. | Health care | Santa Clara | Series B | $31.0M | 2025-01-08 | $54.4M | Sunstone Management, SV Tech Ventures, Shangbay Capital +1 | 11 to 50 | 2014 |
Table 1. Health care startups that raised Series B in California, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 441.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Mirador Therapeutics | Mirador Therapeutics develops precision medicines for immune-mediated diseases. | Biotech | San Diego | Series B | $250.0M | 2026-01-12 | $730.0M | OrbiMed, Fidelity, ARCH Venture Partners +1 | 11 to 50 | 2024 |
| 2 | Qualified Health | Qualified Health develops AI tools that support clinical decisions and patient care management. | Artificial intelligence | San Carlos | Series B | $125.0M | 2026-03-25 | $155.0M | SignalFire, Flare Capital Partners, Town Hall Ventures +1 | 51 to 100 | 2023 |
| 3 | Aureka Biotechnologies | Aureka Biotechnologies uses AI to discover protein therapeutics and antibody treatments. | Artificial intelligence | Laguna Hills | Series B | $100.0M | 2026-08-10 | $168.4M | K2VC, NRL Capital | 11 to 50 | 2023 |
| 4 | BlossomHill Therapeutics | BlossomHill Therapeutics is a biopharmaceutical company focused on oncology and autoimmune disorders. | Biotech | San Diego | Series B | $84.0M | 2025-12-10 | $257.0M | OrbiMed, Cormorant Asset Management, Vivo Capital +2 | 11 to 50 | 2020 |
| 5 | Apella Technology | Apella Technology is an AI company that applies modern engineering to improve surgical procedures. | Artificial intelligence | Oakland | Series B | $80.0M | 2026-01-07 | $104.0M | Operator Partners, Upside Partnership, Casdin Capital +1 | 51 to 100 | 2019 |
| 6 | Multiply Labs | Multiply Labs builds robotic systems that automate biologics manufacturing. | Artificial intelligence | San Francisco | Series B | $75.0M | 2026-10-06 | $97.7M | Y Combinator, Founders Fund, Garage Capital +2 | 11 to 50 | 2016 |
| 7 | Moonwalk Biosciences | Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. | Artificial intelligence | South San Francisco | Series B | $70.0M | 2026-09-08 | $127.0M | Google Ventures, Khosla Ventures, ARCH Venture Partners +2 | 11 to 50 | 2022 |
| 8 | BreezeBio | BreezeBio is a biotechnology company that develops genetic therapies using non-viral delivery to clinically important tissues. | Artificial intelligence | Brisbane | Series B | $60.0M | 2026-02-25 | $127.7M | Sequoia Capital, National Science Foundation, Qiming Venture Partners +1 | 51 to 100 | 2016 |
| 9 | Aeovian Pharmaceuticals | Aeovian Pharmaceuticals develops and commercializes therapeutics for rare and age-related diseases. | Biotech | San Francisco | Series B | $55.0M | 2025-12-16 | $142.0M | Sofinnova Investments, venBio Partners, Apollo Health Ventures | 1 to 10 | 2012 |
| 10 | Prolific Machines | Prolific Machines develops light-controlled gene expression systems for producing therapeutics. | Artificial intelligence | Emeryville | Series B | $50.0M | 2026-10-14 | $147.0M | SOSV, Mayfield Fund, SOSV SF & NY (Fka IndieBio) +2 | 51 to 100 | 2020 |
Table 2. Health care startups that raised Series B in California, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Y Combinator | Startup accelerator | Mountain View, United States | 6 | 1% | 3 | Multiply Labs, Bunkerhill Health, Triomics |
| 2 | Founders Fund | Venture capital firm | San Francisco, United States | 5 | 1% | 2 | Multiply Labs, 9amHealth |
| 3 | Google Ventures | Corporate venture arm | San Francisco, United States | 5 | 1% | 1 | Moonwalk Biosciences |
| 4 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 5 | 1% | 2 | Moonwalk Biosciences, Mirador Therapeutics |
| 5 | National Science Foundation | Entrepreneurship program | Alexandria, United States | 5 | 1% | 1 | BreezeBio |
| 6 | OrbiMed | Private equity firm | New York, United States | 5 | 1% | 2 | Mirador Therapeutics, BlossomHill Therapeutics |
| 7 | Lux Capital | Venture capital firm | New York, United States | 5 | 1% | ||
| 8 | Andreessen Horowitz | Venture capital firm | Menlo Park, United States | 5 | 1% | ||
| 9 | SOSV | Venture capital firm | Princeton, United States | 4 | 1% | 1 | Prolific Machines |
| 10 | Khosla Ventures | Venture capital firm | Menlo Park, United States | 4 | 1% | 1 | Moonwalk Biosciences |
| 11 | General Catalyst | Venture capital firm | San Francisco, United States | 4 | 1% | 2 | Faro AI, Triomics |
| 12 | Plug and Play | Startup accelerator | Sunnyvale, United States | 4 | 1% | ||
| 13 | Samsara BioCapital | Private equity firm | Palo Alto, United States | 4 | 1% | ||
| 14 | Bossa Invest | Venture capital firm | São Paulo, Brazil | 4 | 1% | ||
| 15 | Techstars | Startup accelerator | New York, United States | 4 | 1% |
Table 3. Health care startups that raised Series B in California, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 203 | 46% | $17.2B |
| Software | 112 | 25% | $5.9B |
| Artificial intelligence | 49 | 11% | $3.5B |
| Hardware | 25 | 6% | $736.8M |
| Commerce | 17 | 4% | $587.0M |
| Fintech | 13 | 3% | $393.8M |
| Education | 4 | 1% | $346.4M |
| Cybersecurity | 1 | 0% | $22.0M |
Table 4. Health care startups that raised Series B in California, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 441 | 100% | $25.0M |
Table 5. Health care startups that raised Series B in California, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| San Francisco | 88 | 20% |
| San Diego | 60 | 14% |
| Palo Alto | 25 | 6% |
| Los Angeles | 22 | 5% |
| San Jose | 16 | 4% |
| South San Francisco | 13 | 3% |
| Mountain View | 11 | 2% |
| San Mateo | 11 | 2% |
| Menlo Park | 11 | 2% |
| Irvine | 11 | 2% |
| Fremont | 9 | 2% |
| Redwood City | 8 | 2% |
Table 6. Health care startups that raised Series B in California, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 5 | 10% | $345.8M |
| September 2026 | 4 | 8% | $132.0M |
| August 2026 | 6 | 12% | $332.3M |
| July 2026 | 5 | 10% | $170.0M |
| June 2026 | 8 | 16% | $534.1M |
| May 2026 | 3 | 6% | $86.0M |
| April 2026 | 4 | 8% | $316.5M |
| March 2026 | 2 | 4% | $170.0M |
| February 2026 | 1 | 2% | $60.0M |
| January 2026 | 8 | 16% | $545.3M |
| December 2025 | 4 | 8% | $284.0M |
| November 2025 | 1 | 2% | $23.0M |
Table 7. Health care startups that raised Series B in California, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 46 | 10% | $2.7B |
| 2025 | 46 | 10% | $2.1B |
| 2024 | 45 | 10% | $2.2B |
| 2023 | 30 | 7% | $1.1B |
| 2022 | 30 | 7% | $893.3M |
| 2021 | 50 | 11% | $2.3B |
Table 8. Health care startups that raised Series B in California, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 14 | 3% |
| 2020 to 2022 | 53 | 12% |
| 2015 to 2019 | 163 | 37% |
| 2010 to 2014 | 114 | 26% |
| Before 2010 | 95 | 22% |
Table 9. Health care startups that raised Series B in California, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 75 | 17% |
| 11 to 50 | 209 | 48% |
| 51 to 100 | 83 | 19% |
| 101 to 250 | 46 | 10% |
| 251 to 500 | 13 | 3% |
| 501 to 1,000 | 6 | 1% |
| 1,001 to 5,000 | 3 | 1% |
| 5,001 to 10,000 | 2 | 0% |
| 10,001 or more | 2 | 0% |
Table 10. Health care startups that raised Series B in California, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series B and its headquarters is in California, United States. On 16 November 2026 that is 441 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 30 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 441 rows: 41 have no round amount, 0 no city and 42 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in California, United States whose last round is Series B are on the list?
- 441, in the file dated 16 November 2026. 51 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 441 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.